These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy]. Mishina M; Senda M; Ohyama M; Ishii K; Kitamura S; Terashi A Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328 [TBL] [Abstract][Full Text] [Related]
24. [A longitudinal study of CMRGlu in dementia of Alzheimer type]. Kuwabara Y; Ichiya Y; Ichimiya A; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K Kaku Igaku; 1994 Oct; 31(10):1255-60. PubMed ID: 7807730 [TBL] [Abstract][Full Text] [Related]
25. Topographic patterns of brain functional impairment progression according to clinical severity staging in 116 Alzheimer disease patients: FDG-PET study. Choo IH; Lee DY; Youn JC; Jhoo JH; Kim KW; Lee DS; Lee JS; Woo JI Alzheimer Dis Assoc Disord; 2007; 21(2):77-84. PubMed ID: 17545731 [TBL] [Abstract][Full Text] [Related]
26. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126 [TBL] [Abstract][Full Text] [Related]
27. Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type. Mielke R; Herholz K; Grond M; Kessler J; Heiss WD Neurobiol Aging; 1992; 13(1):93-8. PubMed ID: 1542386 [TBL] [Abstract][Full Text] [Related]
28. Cortical abnormalities in Alzheimer's disease. Foster NL; Chase TN; Mansi L; Brooks R; Fedio P; Patronas NJ; Di Chiro G Ann Neurol; 1984 Dec; 16(6):649-54. PubMed ID: 6335378 [TBL] [Abstract][Full Text] [Related]
29. Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-D-glucose: healthy aging, Alzheimer's disease and Down syndrome. Cutler NR Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):309-21. PubMed ID: 2948218 [TBL] [Abstract][Full Text] [Related]
30. Cerebral metabolic and cognitive studies in dementia with frontal lobe behavioral features. Kumar A; Schapiro MB; Haxby JV; Grady CL; Friedland RP J Psychiatr Res; 1990; 24(2):97-109. PubMed ID: 2213642 [TBL] [Abstract][Full Text] [Related]
31. A double FDG/PET study of the effects of scopolamine in older adults. Molchan SE; Matochik JA; Zametkin AJ; Szymanski HV; Cantillon M; Cohen RM; Sunderland T Neuropsychopharmacology; 1994 May; 10(3):191-8. PubMed ID: 7916916 [TBL] [Abstract][Full Text] [Related]
32. Brain metabolism in autism. Resting cerebral glucose utilization rates as measured with positron emission tomography. Rumsey JM; Duara R; Grady C; Rapoport JL; Margolin RA; Rapoport SI; Cutler NR Arch Gen Psychiatry; 1985 May; 42(5):448-55. PubMed ID: 3872650 [TBL] [Abstract][Full Text] [Related]
33. Association between brain functional failure and dementia severity in Alzheimer's disease: resting versus stimulation PET study. Pietrini P; Furey ML; Alexander GE; Mentis MJ; Dani A; Guazzelli M; Rapoport SI; Schapiro MB Am J Psychiatry; 1999 Mar; 156(3):470-3. PubMed ID: 10080567 [TBL] [Abstract][Full Text] [Related]
34. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease. McGeer PL; Kamo H; Harrop R; Li DK; Tuokko H; McGeer EG; Adam MJ; Ammann W; Beattie BL; Calne DB CMAJ; 1986 Mar; 134(6):597-607. PubMed ID: 3512063 [TBL] [Abstract][Full Text] [Related]
35. Age differences in intercorrelations between regional cerebral metabolic rates for glucose. Horwitz B; Duara R; Rapoport SI Ann Neurol; 1986 Jan; 19(1):60-7. PubMed ID: 3484930 [TBL] [Abstract][Full Text] [Related]
36. Comparability of FDG PET studies in probable Alzheimer's disease. Herholz K; Perani D; Salmon E; Franck G; Fazio F; Heiss WD; Comar D J Nucl Med; 1993 Sep; 34(9):1460-6. PubMed ID: 8355064 [TBL] [Abstract][Full Text] [Related]
37. Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET. Kushner M; Tobin M; Alavi A; Chawluk J; Rosen M; Fazekas F; Alavi J; Reivich M J Nucl Med; 1987 Nov; 28(11):1667-70. PubMed ID: 3499490 [TBL] [Abstract][Full Text] [Related]
38. [Cerebral glucose metabolism in autistic children. Study and positron emission tomography]. De Volder AG; Bol A; Michel C; Cogneau M; Goffinet AM Acta Neurol Belg; 1988; 88(2):75-90. PubMed ID: 3260437 [TBL] [Abstract][Full Text] [Related]
39. Imaging local brain function with emission computed tomography. Kuhl DE Radiology; 1984 Mar; 150(3):625-31. PubMed ID: 6607481 [TBL] [Abstract][Full Text] [Related]
40. Positron emission tomography and familial Alzheimer's disease: a pilot study. Guze BH; Hoffman JM; Mazziotta JC; Baxter LR; Phelps ME J Am Geriatr Soc; 1992 Feb; 40(2):120-3. PubMed ID: 1740595 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]